Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 10/2010

01-10-2010 | Head and Neck

Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?

Authors: Stephan K. Haerle, G. F. Huber, T. F. Hany, N. Ahmad, D. T. Schmid

Published in: European Archives of Oto-Rhino-Laryngology | Issue 10/2010

Login to get access

Abstract

18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET)/CT imaging of squamous cell carcinoma of the head and neck (HNSCC) renders the possibility to study metabolic tumor activity by measuring FDG-uptake expressed as maximum standardized uptake value (SUVmax). A correlation between SUVmax and several factors including T-classification, histological tumor differentiation or different anatomic subsites is of potential interest in HNSCC. The aim of this study was to evaluate how metabolic tumor activity derived from FDG-PET correlates with prognostic clinical and pathological parameters including these factors. 262 patients with HNSCC undergoing PET/CT for initial staging were assessed separately for a potential correlation between SUVmax and T-classification, histological grading, and anatomical subsites of the primary tumor. Nonparametric testing showed a significant correlation between SUVmax and T-classification (P < 0.001). On the contrary, no statistically significant correlation was found between SUVmax and histological tumor grading. Furthermore, no statistical significant correlation between the different anatomical subsites and SUVmax were found. There was no significant correlation of SUVmax and tumor grading after adjustment for T-stage and anatomical localization of the tumor, neither. Conclusion: Metabolic tumor activity correlates with T-stage of HNSCC. However, histological tumor grading does not correlate with SUVmax. The role of primary tumor SUVmax as a predictor of outcome or survival remains unclear. Clinicians should therefore exercise caution in attributing any clinical importance to SUVmax obtained from a single PET/CT exam.
Literature
1.
go back to reference Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF (2009) Head and neck squamous cell carcinoma (HNSCC): detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging 36:919–927. doi:10.1007/s00259-009-1064-6 CrossRefPubMed Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF (2009) Head and neck squamous cell carcinoma (HNSCC): detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging 36:919–927. doi:10.​1007/​s00259-009-1064-6 CrossRefPubMed
2.
go back to reference Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ (2010) (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck 32:319–325. doi:10.1002/hed.21184 PubMed Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ (2010) (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck 32:319–325. doi:10.​1002/​hed.​21184 PubMed
3.
go back to reference Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, Bridji B, Digue L, Toubeau M, Gregoire V (2010) Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol 28:1190–1195. doi:10.1200/JCO.2009.24.6298 CrossRefPubMed Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, Bridji B, Digue L, Toubeau M, Gregoire V (2010) Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol 28:1190–1195. doi:10.​1200/​JCO.​2009.​24.​6298 CrossRefPubMed
4.
go back to reference Uyl-de Groot CA, Senft A, de Bree R, Leemans CR, Hoekstra OS (2010) Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients. J Nucl Med 51:176–182. doi:10.2967/jnumed.109.067371 CrossRefPubMed Uyl-de Groot CA, Senft A, de Bree R, Leemans CR, Hoekstra OS (2010) Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients. J Nucl Med 51:176–182. doi:10.​2967/​jnumed.​109.​067371 CrossRefPubMed
6.
go back to reference Machtay M, Natwa M, Andrel J, Hyslop T, Anne PR, Lavarino J, Intenzo CM, Keane W (2009) Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31:195–201. doi:10.1002/hed.20942 CrossRefPubMed Machtay M, Natwa M, Andrel J, Hyslop T, Anne PR, Lavarino J, Intenzo CM, Keane W (2009) Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31:195–201. doi:10.​1002/​hed.​20942 CrossRefPubMed
7.
go back to reference Maccomb W, Fletcher G (196) Cancer of the head and neck. Williams & Wilkins Company, Baltimore, pp 152–292 Maccomb W, Fletcher G (196) Cancer of the head and neck. Williams & Wilkins Company, Baltimore, pp 152–292
8.
go back to reference Chen RB, Suzuki K, Nomura T, Nakajima T (1993) Flow cytometric analysis of squamous cell carcinomas of the oral cavity in relation to lymph node metastasis. J Oral Maxillofac Surg 51:397–401CrossRefPubMed Chen RB, Suzuki K, Nomura T, Nakajima T (1993) Flow cytometric analysis of squamous cell carcinomas of the oral cavity in relation to lymph node metastasis. J Oral Maxillofac Surg 51:397–401CrossRefPubMed
9.
go back to reference Goerkem M, Braun J, Stoeckli SJ (2010) Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity. Ann Surg Oncol 17:527–535. doi:10.1245/s10434-009-0755-3 CrossRefPubMed Goerkem M, Braun J, Stoeckli SJ (2010) Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity. Ann Surg Oncol 17:527–535. doi:10.​1245/​s10434-009-0755-3 CrossRefPubMed
10.
go back to reference Suzuki K, Nishioka T, Homma A, Tsuchiya K, Yasuda M, Aoyama H, Onimaru R, Tamaki N, Shirato H (2009) Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome? Jpn J Radiol 27:237–242. doi:10.1007/s11604-009-0330-7 CrossRefPubMed Suzuki K, Nishioka T, Homma A, Tsuchiya K, Yasuda M, Aoyama H, Onimaru R, Tamaki N, Shirato H (2009) Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome? Jpn J Radiol 27:237–242. doi:10.​1007/​s11604-009-0330-7 CrossRefPubMed
11.
go back to reference Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL (1999) Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 213:521–525PubMed Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL (1999) Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 213:521–525PubMed
12.
go back to reference Schmid DT, Stoeckli SJ, Bandhauer F, Huguenin P, Schmid S, von Schulthess GK, Goerres GW (2003) Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 113:888–891. doi:10.1097/00005537-200305000-00021 CrossRefPubMed Schmid DT, Stoeckli SJ, Bandhauer F, Huguenin P, Schmid S, von Schulthess GK, Goerres GW (2003) Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 113:888–891. doi:10.​1097/​00005537-200305000-00021 CrossRefPubMed
13.
go back to reference Hustinx R, Lucignani G (2010) PET/CT in head and neck cancer: an update. Eur J Nucl Med Mol Imaging 37:645–651CrossRefPubMed Hustinx R, Lucignani G (2010) PET/CT in head and neck cancer: an update. Eur J Nucl Med Mol Imaging 37:645–651CrossRefPubMed
14.
go back to reference Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y (2003) FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30:63–71. doi:10.1007/s00259-002-0978-z CrossRefPubMed Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y (2003) FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30:63–71. doi:10.​1007/​s00259-002-0978-z CrossRefPubMed
16.
go back to reference Brun E, Kjellen E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Wennerberg J, Strand SE (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24:127–135. doi:10.1002/hed.10037 CrossRefPubMed Brun E, Kjellen E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Wennerberg J, Strand SE (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24:127–135. doi:10.​1002/​hed.​10037 CrossRefPubMed
17.
go back to reference Allal AS, Dulguerov P, Allaoua M, Haenggeli CA, El-Ghazi el A, Lehmann W, Slosman DO (2002) Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20:1398–1404CrossRefPubMed Allal AS, Dulguerov P, Allaoua M, Haenggeli CA, El-Ghazi el A, Lehmann W, Slosman DO (2002) Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20:1398–1404CrossRefPubMed
18.
go back to reference Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Naitou K, Ueda Y, Ouchi Y (2009) Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. AJR Am J Roentgenol 192:W156–W160. doi:10.2214/AJR.08.1429 CrossRefPubMed Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Naitou K, Ueda Y, Ouchi Y (2009) Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. AJR Am J Roentgenol 192:W156–W160. doi:10.​2214/​AJR.​08.​1429 CrossRefPubMed
20.
go back to reference Agarwal JP, Mallick I, Bhutani R, Ghosh-Laskar S, Gupta T, Budrukkar A, Murthy V, Sengar M, Dinshaw KA (2009) Prognostic factors in oropharyngeal cancer-analysis of 627 cases receiving definitive radiotherapy. Acta Oncol 48:1026–1033. doi:10.1080/02841860902845839 CrossRefPubMed Agarwal JP, Mallick I, Bhutani R, Ghosh-Laskar S, Gupta T, Budrukkar A, Murthy V, Sengar M, Dinshaw KA (2009) Prognostic factors in oropharyngeal cancer-analysis of 627 cases receiving definitive radiotherapy. Acta Oncol 48:1026–1033. doi:10.​1080/​0284186090284583​9 CrossRefPubMed
21.
go back to reference Ioannidis JP, Lau J (2003) 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med 44:717–724PubMed Ioannidis JP, Lau J (2003) 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med 44:717–724PubMed
22.
go back to reference Ensley J, Crissman J, Kish J, Jacobs J, Weaver A, Kinzie J, Cummings G, Al-Sarraf M (1986) The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin-containing combination chemotherapy. Cancer 57:711–717CrossRefPubMed Ensley J, Crissman J, Kish J, Jacobs J, Weaver A, Kinzie J, Cummings G, Al-Sarraf M (1986) The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin-containing combination chemotherapy. Cancer 57:711–717CrossRefPubMed
Metadata
Title
Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?
Authors
Stephan K. Haerle
G. F. Huber
T. F. Hany
N. Ahmad
D. T. Schmid
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 10/2010
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-010-1348-2

Other articles of this Issue 10/2010

European Archives of Oto-Rhino-Laryngology 10/2010 Go to the issue